More Patients and Medical Articles

Patients and Medical

I Made An App To Plug A Knowledge Gap

Lucy Fulford, (Oct 24, 2018)

Hellen Marguerite Juul struggled to find information on how to navigate a pregnancy with diabetes, so she came up with her own solution.
Patients and Medical

The Discovery That Changed My Life

Lucy Fulford, (Oct 8, 2018)

For Rocco Falchetto, stepping into the sun was extremely painful. Then one day, everything changed.
Patients and Medical

Patients: The New Architects Of Clinical Trials?

Danielle Barron, (Oct 4, 2018)

The industry has long flirted with the idea of getting patients to design clinical trials. But is the idea coming to fruition?
Patients and Medical

Are Your MSLs The Real Deal?

Adam Chapman, (Sep 27, 2018)

An MSL must ooze authenticity. Science depends on it.
Patients and Medical

A Career-Defining Diagnosis

Hugh Gosling, (Sep 26, 2018)

Roche's Jay Graves doesn't just live with diabetes, he works with it. This is his story.
Patients and Medical

When Patients Take Control

Hugh Gosling, (Sep 18, 2018)

Ever wondered what a pharma event created, designed and run by patients would look like? Paul Simms was curious, so he created the Im-Patient Conference
Patients and Medical

Co-Creation With Patients: A Stellar Combo?

Hugh Gosling, (Sep 5, 2018)

Only by working closely with patients can pharma deliver the best products and services. Read our practical guide to co-creating with patients.
Patients and Medical

Why Patient Organizations Are No Summer Fling For Pharma

Adam Chapman, (Aug 8, 2018)

Pharma companies are forming long-term relationships with patient organizations, a move that is already bearing fruits for both parties.
Patients and Medical

Flying The Flag For Patients

Hugh Gosling, (Aug 2, 2018)

The Chief Patient Officer is pharma’s face of patient-centricity but how is this relatively new role shaping up?
Patients and Medical

Five Reasons Why Clinical Trials Fail And What Pharma is Doing To Fix It

Adam Chapman, (Jul 27, 2018)

Clinical trial recruitment is a perennial challenge for pharma. Are they listening to patients?

Pages